Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to 1.12%.

  • TriSalus Life Sciences' Return on Capital Employed rose 10200.0% to 1.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.12%, marking a year-over-year increase of 10200.0%. This contributed to the annual value of 2.57% for FY2024, which is 37500.0% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Return on Capital Employed stood at 1.12%, which was up 10200.0% from 1.21% recorded in Q2 2025.
  • TriSalus Life Sciences' 5-year Return on Capital Employed high stood at 0.2% for Q4 2022, and its period low was 8.17% during Q1 2024.
  • Its 4-year average for Return on Capital Employed is 2.9%, with a median of 2.26% in 2025.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -63500bps in 2024, then skyrocketed by 59800bps in 2025.
  • TriSalus Life Sciences' Return on Capital Employed (Quarter) stood at 0.2% in 2022, then tumbled by -1793bps to 3.78% in 2023, then soared by 38bps to 2.33% in 2024, then surged by 52bps to 1.12% in 2025.
  • Its Return on Capital Employed was 1.12% in Q3 2025, compared to 1.21% in Q2 2025 and 2.19% in Q1 2025.